{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:32:31Z","timestamp":1792859551303,"version":"4.5.0"},"reference-count":145,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ministry of Higher Education","award":["FRGS\/1\/2019\/SKK08\/UKM\/01\/4"],"award-info":[{"award-number":["FRGS\/1\/2019\/SKK08\/UKM\/01\/4"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s10571-020-00979-z","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T07:03:06Z","timestamp":1603090986000},"page":"577-595","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Epigenetic Changes and Its Intervention in Age-Related Neurodegenerative Diseases"],"prefix":"10.1007","volume":"42","author":[{"given":"Nuraqila","family":"Mohd Murshid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faridah","family":"Aminullah Lubis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5239-6196","authenticated-orcid":false,"given":"Suzana","family":"Makpol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"issue":"1","key":"979_CR1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coph.2007.12.002","volume":"8","author":"T Abel","year":"2008","unstructured":"Abel T, Zukin RS (2008) Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr Opin Pharmacol 8(1):57\u201364","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"979_CR2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pharmthera.2013.03.010","volume":"139","author":"L Adwan","year":"2013","unstructured":"Adwan L, Zawia NH (2013) Epigenetics: a novel therapeutic approach for the treatment of Alzheimer\u2019s disease. Pharmacol Ther 139(1):41\u201350","journal-title":"Pharmacol Ther"},{"issue":"2","key":"979_CR3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1360-0443.2010.03218.x","volume":"106","author":"P Ambermoon","year":"2011","unstructured":"Ambermoon P, Carter A, Hall WD, Dissanayaka NN, O\u2019Sullivan JD (2011) Impulse control disorders in patients with Parkinson\u2019s disease receiving dopamine replacement therapy: evidence and implications for the addictions field. Addiction 106(2):283\u2013293","journal-title":"Addiction"},{"issue":"3","key":"979_CR4","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.nbd.2012.03.009","volume":"46","author":"D Antequera","year":"2012","unstructured":"Antequera D, Bolos M, Spuch C, Pascual C, Ferrer I, Fernandez-Bachiller MI, Rodr\u00edguez-Franco MI, Carro E (2012) Effects of a tacrine-8-hydroxyquinoline hybrid (IQM-622) on A\u03b2 accumulation and cell death: involvement in hippocampal neuronal loss in Alzheimer\u2019s disease. Neurobiol Dis 46(3):682\u2013691","journal-title":"Neurobiol Dis"},{"issue":"9","key":"979_CR5","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/gps.4074","volume":"29","author":"T Araki","year":"2014","unstructured":"Araki T, Wake R, Miyaoka T, Kawakami K, Nagahama M, Furuya M, Limoa E, Liaury K, Hashioka S, Murotani K (2014) The effects of combine treatment of memantine and donepezil on Alzheimer\u2019s disease patients and its relationship with cerebral blood flow in the prefrontal area. Int J Geriatr Psychiatry 29(9):881\u2013889","journal-title":"Int J Geriatr Psychiatry"},{"issue":"7","key":"979_CR6","doi-asserted-by":"crossref","first-page":"20629","DOI":"10.1371\/journal.pone.0020629","volume":"6","author":"M Arikawa","year":"2011","unstructured":"Arikawa M, Kakinuma Y, Handa T, Yamasaki F, Sato T (2011) Donepezil, anti-Alzheimer\u2019s disease drug, prevents cardiac rupture during acute phase of myocardial infarction in mice. PLoS ONE 6(7):20629","journal-title":"PLoS ONE"},{"key":"979_CR7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1820838116","author":"MJ Aristizabal","year":"2019","unstructured":"Aristizabal MJ, Anreiter I, Halldorsdottir T, Odgers CL, McDade TW, Goldenberg A, Mostafavi S, Kobor MS, Binder EB, Sokolowski MB (2019) Biological embedding of experience: a primer on epigenetics. Proc Natl Acad Sci. https:\/\/doi.org\/10.1073\/pnas.1820838116","journal-title":"Proc Natl Acad Sci"},{"issue":"9288","key":"979_CR8","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(01)06260-2","volume":"358","author":"RJ Armstrong","year":"2001","unstructured":"Armstrong RJ, Barker RA (2001) Neurodegeneration: a failure of neuroregeneration? The Lancet 358(9288):1174\u20131176","journal-title":"The Lancet"},{"issue":"3","key":"979_CR9","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3233\/JAD-2012-111223","volume":"29","author":"KM Bakulski","year":"2012","unstructured":"Bakulski KM, Dolinoy DC, Sartor MA, Paulson HL, Konen JR, Lieberman AP, Albin RL, Hu H, Rozek LS (2012) Genome-wide DNA methylation differences between late-onset Alzheimer\u2019s disease and cognitively normal controls in human frontal cortex. J Alzheimer\u2019s Dis 29(3):571\u2013588","journal-title":"J Alzheimer's Dis"},{"issue":"1","key":"979_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-020-00596-4","volume":"12","author":"NR Barth\u00e9lemy","year":"2020","unstructured":"Barth\u00e9lemy NR, Bateman RJ, Hirtz C, Marin P, Becher F, Sato C, Gabelle A, Lehmann S (2020) Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer\u2019s disease and PET amyloid-positive patient identification. Alzheimer\u2019s Res Therapy 12(1):1\u201311","journal-title":"Alzheimer's Res Therapy"},{"issue":"9","key":"979_CR11","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tins.2018.05.005","volume":"41","author":"A Berson","year":"2018","unstructured":"Berson A, Nativio R, Berger SL, Bonini NM (2018) Epigenetic regulation in neurodegenerative diseases. Trends Neurosci 41(9):587\u2013598","journal-title":"Trends Neurosci"},{"issue":"5","key":"979_CR12","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0896-6273(00)80230-5","volume":"17","author":"DR Borchelt","year":"1996","unstructured":"Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, Prada C-M, Kim G, Seekins S, Yager D (1996) Familial Alzheimer\u2019s disease\u2013linked presenilin 1 variants elevate A\u03b21\u201342\/1\u201340 ratio in vitro and in vivo. Neuron 17(5):1005\u20131013","journal-title":"Neuron"},{"issue":"7","key":"979_CR13","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/nm1067","volume":"10","author":"E Bossy-Wetzel","year":"2004","unstructured":"Bossy-Wetzel E, Schwarzenbacher R, Lipton SA (2004) Molecular pathways to neurodegeneration. Nat Med 10(7):S2\u2013S9","journal-title":"Nat Med"},{"issue":"9","key":"979_CR14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrn3992","volume":"16","author":"T Bourgeron","year":"2015","unstructured":"Bourgeron T (2015) From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nat Rev Neurosci 16(9):551\u2013563","journal-title":"Nat Rev Neurosci"},{"key":"979_CR15","first-page":"453","volume-title":"Epigenetic drug discovery for Alzheimer\u2019s disease. In: Epigenetics of aging and longevity","author":"R Cacabelos","year":"2018","unstructured":"Cacabelos R, Teijido O (2018) Epigenetic drug discovery for Alzheimer\u2019s disease. In: Epigenetics of aging and longevity. Elsevier, New York, pp 453\u2013495"},{"issue":"4","key":"979_CR16","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3233\/JAD-2010-091666","volume":"20","author":"RA Cavallaro","year":"2010","unstructured":"Cavallaro RA, Fuso A, Nicolia V, Scarpa S (2010) S-adenosylmethionine prevents oxidative stress and modulates glutathione metabolism in TgCRND8 mice fed a B-vitamin deficient diet. J Alzheimer\u2019s Dis 20(4):997\u20131002","journal-title":"J Alzheimer's Dis"},{"issue":"6","key":"979_CR17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/1533317508325093","volume":"23","author":"A Chan","year":"2009","unstructured":"Chan A, Paskavitz J, Remington R, Rasmussen S, Shea TB (2009) Efficacy of a vitamin\/nutriceutical formulation for early-stage Alzheimer\u2019s disease: a 1-year, open-label pilot study with an 16-month caregiver extension. Am J Alzheimer\u2019s Dis Other Demen 23(6):571\u2013585","journal-title":"Am J Alzheimer's Dis Other Demen"},{"issue":"33","key":"979_CR18","doi-asserted-by":"crossref","first-page":"11390","DOI":"10.1523\/JNEUROSCI.0757-12.2012","volume":"32","author":"Y Chen","year":"2012","unstructured":"Chen Y, Huang X, Zhang Y-w, Rockenstein E, Bu G, Golde TE, Masliah E, Xu H (2012) Alzheimer\u2019s \u03b2-secretase (BACE1) regulates the cAMP\/PKA\/CREB pathway independently of \u03b2-amyloid. J Neurosci 32(33):11390\u201311395","journal-title":"J Neurosci"},{"issue":"2","key":"979_CR19","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.canlet.2014.10.012","volume":"356","author":"MG Cheon","year":"2015","unstructured":"Cheon MG, Kim W, Choi M, Kim J-E (2015) AK-1, a specific SIRT2 inhibitor, induces cell cycle arrest by downregulating Snail in HCT116 human colon carcinoma cells. Cancer Lett 356(2):637\u2013645","journal-title":"Cancer Lett"},{"issue":"6","key":"979_CR20","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.celrep.2012.11.001","volume":"2","author":"V Chopra","year":"2012","unstructured":"Chopra V, Quinti L, Kim J, Vollor L, Narayanan KL, Edgerly C, Cipicchio PM, Lauver MA, Choi SH, Silverman RB (2012) The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington\u2019s disease mouse models. Cell Rep 2(6):1492\u20131497","journal-title":"Cell Rep"},{"key":"979_CR21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mad.2017.12.002","volume":"174","author":"F Ciccarone","year":"2018","unstructured":"Ciccarone F, Tagliatesta S, Caiafa P, Zampieri M (2018) DNA methylation dynamics in aging: how far are we from understanding the mechanisms? Mech Ageing Dev 174:3\u201317","journal-title":"Mech Ageing Dev"},{"issue":"2","key":"979_CR22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0022-2836(77)90214-5","volume":"116","author":"DW Cleveland","year":"1977","unstructured":"Cleveland DW, Hwo S-Y, Kirschner MW (1977) Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. J Mol Biol 116(2):227\u2013247","journal-title":"J Mol Biol"},{"key":"979_CR23","first-page":"220","volume":"5","author":"F Copped\u00e8","year":"2014","unstructured":"Copped\u00e8 F (2014) The potential of epigenetic therapies in neurodegenerative diseases. Front Genet 5:220","journal-title":"Front Genet"},{"issue":"3","key":"979_CR24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.yhbeh.2010.06.018","volume":"59","author":"JP Curley","year":"2011","unstructured":"Curley JP, Mashoodh R, Champagne FA (2011) Epigenetics and the origins of paternal effects. Horm Behav 59(3):306\u2013314","journal-title":"Horm Behav"},{"issue":"3","key":"979_CR25","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0896-6273(00)80998-8","volume":"20","author":"JA Davis","year":"1998","unstructured":"Davis JA, Naruse S, Chen H, Eckman C, Younkin S, Price DL, Borchelt DR, Sisodia SS, Wong PC (1998) An Alzheimer\u2019s disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos. Neuron 20(3):603\u2013609","journal-title":"Neuron"},{"issue":"9","key":"979_CR26","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/nn.3786","volume":"17","author":"PL De Jager","year":"2014","unstructured":"De Jager PL et al (2014) Alzheimer\u2019s disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci 17(9):1156\u20131163","journal-title":"Nat Neurosci"},{"issue":"6665","key":"979_CR27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/34910","volume":"391","author":"B De Strooper","year":"1998","unstructured":"De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, Von Figura K, Van Leuven F (1998) Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391(6665):387\u2013390","journal-title":"Nature"},{"issue":"11","key":"979_CR28","doi-asserted-by":"crossref","first-page":"9031","DOI":"10.1074\/jbc.C110.212589","volume":"286","author":"P Desplats","year":"2011","unstructured":"Desplats P, Spencer B, Coffee E, Patel P, Michael S, Patrick C, Adame A, Rockenstein E, Masliah E (2011) \u03b1-Synuclein sequesters Dnmt1 from the nucleus a novel mechanism for epigenetic alterations in lewy body diseases. J Biol Chem 286(11):9031\u20139037","journal-title":"J Biol Chem"},{"issue":"5","key":"979_CR29","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/j.1471-4159.2008.05564.x","volume":"106","author":"H Ding","year":"2008","unstructured":"Ding H et al (2008) Histone deacetylase 6 interacts with the microtubule-associated protein tau. J Neurochem 106(5):2119\u20132130","journal-title":"J Neurochem"},{"issue":"10","key":"979_CR30","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1158\/1541-7786.MCR-07-0324","volume":"5","author":"M Dokmanovic","year":"2007","unstructured":"Dokmanovic M, Clarke C, Marks PA (2007) Histone deacetylase inhibitors: overview and perspectives. Mol Cancer Res 5(10):981\u2013989","journal-title":"Mol Cancer Res"},{"issue":"13","key":"979_CR31","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1523\/JNEUROSCI.0037-07.2007","volume":"27","author":"JP Dompierre","year":"2007","unstructured":"Dompierre JP, Godin JD, Charrin BC, Cordelieres FP, King SJ, Humbert S, Saudou F (2007) Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington\u2019s disease by increasing tubulin acetylation. J Neurosci 27(13):3571\u20133583","journal-title":"J Neurosci"},{"issue":"1","key":"979_CR32","doi-asserted-by":"crossref","first-page":"e16252","DOI":"10.1371\/journal.pone.0016252","volume":"6","author":"O El-Maarri","year":"2011","unstructured":"El-Maarri O, Walier M, Behne F, van \u00dc\u00fcm J, Singer H, Diaz-Lacava A, N\u00fcsgen N, Niemann B, Watzka M, Reinsberg J (2011) Methylation at global LINE-1 repeats in human blood are affected by gender but not by age or natural hormone cycles. PLoS ONE 6(1):e16252","journal-title":"PLoS ONE"},{"issue":"6","key":"979_CR33","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.sjbs.2018.02.005","volume":"25","author":"L Erichsen","year":"2018","unstructured":"Erichsen L, Beermann A, Arauzo-Bravo MJ, Hassan M, Dkhil MA, Al-Quraishy S, Hafiz TA, Fischer JC, Santourlidis S (2018) Genome-wide hypomethylation of LINE-1 and Alu retroelements in cell-free DNA of blood is an epigenetic biomarker of human aging. Saudi J Biol Sci 25(6):1220\u20131226","journal-title":"Saudi J Biol Sci"},{"issue":"1","key":"979_CR34","doi-asserted-by":"crossref","first-page":"223S","DOI":"10.1093\/jn\/137.1.223S","volume":"137","author":"M Fang","year":"2007","unstructured":"Fang M, Chen D, Yang CS (2007) Dietary polyphenols may affect DNA methylation. J Nutr 137(1):223S-228S","journal-title":"J Nutr"},{"issue":"12","key":"979_CR35","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/gps.2669","volume":"26","author":"MR Farlow","year":"2011","unstructured":"Farlow MR, Grossberg GT, Meng X, Olin J, Somogyi M (2011) Rivastigmine transdermal patch and capsule in Alzheimer\u2019s disease: influence of disease stage on response to therapy. Int J Geriatr Psychiatry 26(12):1236\u20131243","journal-title":"Int J Geriatr Psychiatry"},{"key":"979_CR36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fnut.2019.00049","volume":"6","author":"M Feligioni","year":"2019","unstructured":"Feligioni M, Tinelli C, Di Pino A, Ficulle E, Marcelli S (2019) Hyperhomocysteinemia as a risk factor and potential nutraceutical target for certain pathologies. Front Nutr 6:49","journal-title":"Front Nutr"},{"issue":"28","key":"979_CR37","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","volume":"23","author":"RJ Ferrante","year":"2003","unstructured":"Ferrante RJ, Kubilus JK, Lee J, Ryu H, Beesen A, Zucker B, Smith K, Kowall NW, Ratan RR, Luthi-Carter R (2003) Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington\u2019s disease mice. J Neurosci 23(28):9418\u20139427","journal-title":"J Neurosci"},{"issue":"2","key":"979_CR38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neurobiolaging.2009.02.013","volume":"32","author":"A Fuso","year":"2011","unstructured":"Fuso A, Nicolia V, Pasqualato A, Fiorenza MT, Cavallaro RA, Scarpa S (2011) Changes in Presenilin 1 gene methylation pattern in diet-induced B vitamin deficiency. Neurobiol Aging 32(2):187\u2013199","journal-title":"Neurobiol Aging"},{"issue":"1","key":"979_CR39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.mcn.2004.09.007","volume":"28","author":"A Fuso","year":"2005","unstructured":"Fuso A, Seminara L, Cavallaro RA, D\u2019Anselmi F, Scarpa S (2005) S-adenosylmethionine\/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production. Mol Cell Neurosci 28(1):195\u2013204","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"979_CR40","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","volume":"280","author":"G Gardian","year":"2005","unstructured":"Gardian G, Browne SE, Choi D-K, Klivenyi P, Gregorio J, Kubilus JK, Ryu H, Langley B, Ratan RR, Ferrante RJ (2005) Neuroprotective effects of phenylbutyrate in the N171\u201382Q transgenic mouse model of Huntington\u2019s disease. J Biol Chem 280(1):556\u2013563","journal-title":"J Biol Chem"},{"issue":"7","key":"979_CR41","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/35081564","volume":"2","author":"M Goedert","year":"2001","unstructured":"Goedert M (2001) Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci 2(7):492\u2013501","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"979_CR42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3233\/JAD-2011-110080","volume":"26","author":"N Govindarajan","year":"2011","unstructured":"Govindarajan N, Agis-Balboa RC, Walter J, Sananbenesi F, Fischer A (2011) Sodium butyrate improves memory function in an Alzheimer\u2019s disease mouse model when administered at an advanced stage of disease progression. J Alzheimer\u2019s Dis 26(1):187\u2013197","journal-title":"J Alzheimer's Dis"},{"issue":"7388","key":"979_CR43","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10849","volume":"483","author":"J Gr\u00e4ff","year":"2012","unstructured":"Gr\u00e4ff J, Rei D, Guan J-S, Wang W-Y, Seo J, Hennig KM, Nieland TJ, Fass DM, Kao PF, Kahn M (2012) An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature 483(7388):222\u2013226","journal-title":"Nature"},{"issue":"2","key":"979_CR44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nn.3607","volume":"17","author":"JU Guo","year":"2014","unstructured":"Guo JU, Su Y, Shin JH, Shin J, Li H, Xie B, Zhong C, Hu S, Le T, Fan G (2014) Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain. Nat Neurosci 17(2):215","journal-title":"Nat Neurosci"},{"key":"979_CR45","doi-asserted-by":"crossref","first-page":"117278","DOI":"10.1016\/j.lfs.2020.117278","volume":"243","author":"R Gupta","year":"2020","unstructured":"Gupta R, Ambasta RK, Kumar P (2020) Pharmacological intervention of histone deacetylase enzymes in the neurodegenerative disorders. Life Sci 243:117278","journal-title":"Life Sci"},{"issue":"3","key":"979_CR46","first-page":"83","volume":"56","author":"J Halu\u0161kov\u00e1","year":"2010","unstructured":"Halu\u0161kov\u00e1 J (2010) Epigenetic studies in human diseases. Folia Biol (Praha) 56(3):83\u201396","journal-title":"Folia Biol (Praha)"},{"issue":"18","key":"979_CR47","doi-asserted-by":"crossref","first-page":"10469","DOI":"10.1073\/pnas.171202698","volume":"98","author":"ML Hamilton","year":"2001","unstructured":"Hamilton ML, Van Remmen H, Drake JA, Yang H, Guo ZM, Kewitt K, Walter CA, Richardson A (2001) Does oxidative damage to DNA increase with age? Proc Natl Acad Sci 98(18):10469\u201310474","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"979_CR48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2013.05.010","volume":"140","author":"IF Harrison","year":"2013","unstructured":"Harrison IF, Dexter DT (2013) Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson\u2019s disease? Pharmacol Ther 140(1):34\u201352","journal-title":"Pharmacol Ther"},{"issue":"22","key":"979_CR49","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJM200011303432204","volume":"343","author":"S Hern\u00e1ndez-D\u00edaz","year":"2000","unstructured":"Hern\u00e1ndez-D\u00edaz S, Werler MM, Walker AM, Mitchell AA (2000) Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 343(22):1608\u20131614","journal-title":"N Engl J Med"},{"issue":"4","key":"979_CR50","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","volume":"100","author":"E Hockly","year":"2003","unstructured":"Hockly E, Richon VM, Woodman B, Smith DL, Zhou X, Rosa E, Sathasivam K, Ghazi-Noori S, Mahal A, Lowden PA (2003) Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington\u2019s disease. Proc Natl Acad Sci 100(4):2041\u20132046","journal-title":"Proc Natl Acad Sci"},{"issue":"14","key":"979_CR51","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1089\/ars.2016.6695","volume":"25","author":"MA Hoeksema","year":"2016","unstructured":"Hoeksema MA, de Winther MP (2016) Epigenetic regulation of monocyte and macrophage function. Antioxid Redox Signal 25(14):758\u2013774","journal-title":"Antioxid Redox Signal"},{"issue":"41","key":"979_CR52","doi-asserted-by":"crossref","first-page":"17141","DOI":"10.1073\/pnas.1104409108","volume":"108","author":"Y Hu","year":"2011","unstructured":"Hu Y, Chopra V, Chopra R, Locascio JJ, Liao Z, Ding H, Zheng B, Matson WR, Ferrante RJ, Rosas HD (2011) Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse. Proc Natl Acad Sci 108(41):17141\u201317146","journal-title":"Proc Natl Acad Sci"},{"key":"979_CR53","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fnins.2019.00028","volume":"13","author":"M Huang","year":"2019","unstructured":"Huang M, Wang B, Li X, Fu C, Wang C, Kang X (2019) \u03b1-Synuclein: a multifunctional player in exocytosis, endocytosis, and vesicle recycling. Front Neurosci 13:28","journal-title":"Front Neurosci"},{"key":"979_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/8797206","volume":"2016","author":"EE Hull","year":"2016","unstructured":"Hull EE, Montgomery MR, Leyva KJ (2016) HDAC inhibitors as epigenetic regulators of the immune system: impacts on cancer therapy and inflammatory diseases. BioMed Res Int 2016:1\u20136","journal-title":"BioMed Res Int"},{"issue":"1","key":"979_CR55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-5793(94)00395-5","volume":"345","author":"R Jakes","year":"1994","unstructured":"Jakes R, Spillantini MG, Goedert M (1994) Identification of two distinct synucleins from human brain. FEBS Lett 345(1):27\u201332","journal-title":"FEBS Lett"},{"issue":"12","key":"979_CR56","doi-asserted-by":"crossref","first-page":"2967S","DOI":"10.1093\/jn\/135.12.2967S","volume":"135","author":"H Jang","year":"2005","unstructured":"Jang H, Mason JB, Choi S-W (2005) Genetic and epigenetic interactions between folate and aging in carcinogenesis. J Nutr 135(12):2967S-2971S","journal-title":"J Nutr"},{"issue":"1","key":"979_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1582-4934.2001.tb00134.x","volume":"5","author":"K Jellinger","year":"2001","unstructured":"Jellinger K (2001) Cell death mechanisms in neurodegeneration. J Cell Mol Med 5(1):1\u201317","journal-title":"J Cell Mol Med"},{"issue":"2","key":"979_CR58","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.nbd.2012.01.016","volume":"46","author":"H Jia","year":"2012","unstructured":"Jia H, Pallos J, Jacques V, Lau A, Tang B, Cooper A, Syed A, Purcell J, Chen Y, Sharma S (2012) Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington\u2019s disease. Neurobiol Dis 46(2):351\u2013361","journal-title":"Neurobiol Dis"},{"issue":"6","key":"979_CR59","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/1947601910393957","volume":"2","author":"B Jin","year":"2011","unstructured":"Jin B, Li Y, Robertson KD (2011) DNA methylation: superior or subordinate in the epigenetic hierarchy? Genes Cancer 2(6):607\u2013617","journal-title":"Genes Cancer"},{"issue":"10","key":"979_CR60","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrg.2016.93","volume":"17","author":"PA Jones","year":"2016","unstructured":"Jones PA, Issa J-PJ, Baylin S (2016) Targeting the cancer epigenome for therapy. Nat Rev Genet 17(10):630","journal-title":"Nat Rev Genet"},{"issue":"18","key":"979_CR61","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1523\/JNEUROSCI.6119-09.2010","volume":"30","author":"A Jowaed","year":"2010","unstructured":"Jowaed A, Schmitt I, Kaut O, W\u00fcllner U (2010) Methylation regulates alpha-synuclein expression and is decreased in Parkinson\u2019s disease patients\u2019 brains. J Neurosci 30(18):6355\u20136359","journal-title":"J Neurosci"},{"key":"979_CR62","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/02652048.2020.1756971","volume":"37","author":"A Kaur","year":"2020","unstructured":"Kaur A, Nigam K, Srivastava S, Tyagi A, Dang S (2020) Memantine nanoemulsion: a new approach to treat Alzheimer\u2019s Disease. J Microencapsul 37:355\u2013365","journal-title":"J Microencapsul"},{"issue":"1","key":"979_CR63","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10048-011-0308-3","volume":"13","author":"O Kaut","year":"2012","unstructured":"Kaut O, Schmitt I, W\u00fcllner U (2012) Genome-scale methylation analysis of Parkinson\u2019s disease patients\u2019 brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2E1. Neurogenetics 13(1):87\u201391","journal-title":"Neurogenetics"},{"issue":"4","key":"979_CR64","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/npp.2009.197","volume":"35","author":"M Kilgore","year":"2010","unstructured":"Kilgore M, Miller CA, Fass DM, Hennig KM, Haggarty SJ, Sweatt JD, Rumbaugh G (2010) Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer\u2019s disease. Neuropsychopharmacology 35(4):870\u2013880","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"979_CR65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4161\/epi.1.1.2644","volume":"1","author":"T-Y Kim","year":"2006","unstructured":"Kim T-Y, Bang Y-J, Robertson KD (2006) Histone deacetylase inhibitors for cancer therapy. Epigenetics 1(1):15\u201324","journal-title":"Epigenetics"},{"issue":"11","key":"979_CR66","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1093\/jn\/135.11.2703","volume":"135","author":"Y-I Kim","year":"2005","unstructured":"Kim Y-I (2005) Nutritional epigenetics: impact of folate deficiency on DNA methylation and colon cancer susceptibility. J Nutr 135(11):2703\u20132709","journal-title":"J Nutr"},{"issue":"5","key":"979_CR67","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1523\/JNEUROSCI.22-05-01752.2002","volume":"22","author":"II Kruman","year":"2002","unstructured":"Kruman II, Kumaravel T, Lohani A, Pedersen WA, Cutler RG, Kruman Y, Haughey N, Lee J, Evans M, Mattson MP (2002) Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer\u2019s disease. J Neurosci 22(5):1752\u20131762","journal-title":"J Neurosci"},{"issue":"8","key":"979_CR68","doi-asserted-by":"crossref","first-page":"10478","DOI":"10.3390\/ijms130810478","volume":"13","author":"H Kumar","year":"2012","unstructured":"Kumar H, Lim H-W, More SV, Kim B-W, Koppula S, Kim IS, Choi D-K (2012) The role of free radicals in the aging brain and Parkinson\u2019s disease: convergence and parallelism. Int J Mol Sci 13(8):10478\u201310504","journal-title":"Int J Mol Sci"},{"issue":"10","key":"979_CR69","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.embor.7400250","volume":"5","author":"C Landles","year":"2004","unstructured":"Landles C, Bates GP (2004) Huntingtin and the molecular pathogenesis of Huntington\u2019s disease. EMBO Rep 5(10):958\u2013963","journal-title":"EMBO Rep"},{"issue":"32","key":"979_CR70","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1200\/JCO.2009.22.1291","volume":"27","author":"AA Lane","year":"2009","unstructured":"Lane AA, Chabner BA (2009) Histone deacetylase inhibitors in cancer therapy. J Clin Oncol 27(32):5459\u20135468","journal-title":"J Clin Oncol"},{"issue":"4","key":"979_CR71","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s13311-013-0206-5","volume":"10","author":"J Lee","year":"2013","unstructured":"Lee J, Hwang YJ, Kim KY, Kowall NW, Ryu H (2013) Epigenetic mechanisms of neurodegeneration in Huntington\u2019s disease. Neurotherapeutics 10(4):664\u2013676","journal-title":"Neurotherapeutics"},{"issue":"7","key":"979_CR72","doi-asserted-by":"crossref","first-page":"e600","DOI":"10.1038\/tp.2015.90","volume":"5","author":"R Lee","year":"2015","unstructured":"Lee R, Pirooznia M, Guintivano J, Ly M, Ewald E, Tamashiro K, Gould T, Moran TH, Potash JB (2015) Search for common targets of lithium and valproic acid identifies novel epigenetic effects of lithium on the rat leptin receptor gene. Transl Psychiatry 5(7):e600\u2013e600","journal-title":"Transl Psychiatry"},{"issue":"33","key":"979_CR73","doi-asserted-by":"crossref","first-page":"7400","DOI":"10.1523\/JNEUROSCI.1370-04.2004","volume":"24","author":"W Li","year":"2004","unstructured":"Li W, Lesuisse C, Xu Y, Troncoso JC, Price DL, Lee MK (2004) Stabilization of \u03b1-synuclein protein with aging and familial Parkinson\u2019s disease-linked A53T mutation. J Neurosci 24(33):7400\u20137409","journal-title":"J Neurosci"},{"issue":"2","key":"979_CR74","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/00207454.2012.729234","volume":"123","author":"X-z Li","year":"2012","unstructured":"Li X-z, Chen X-p, Zhao K, Bai L-m, Zhang H, Zhou X-p (2012) Therapeutic effects of valproate combined with lithium carbonate on MPTP-induced parkinsonism in mice: possible mediation through enhanced autophagy. Int J Neurosci 123(2):73\u201379","journal-title":"Int J Neurosci"},{"issue":"2","key":"979_CR75","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1527-3458.2002.tb00221.x","volume":"8","author":"S Lilienfeld","year":"2002","unstructured":"Lilienfeld S (2002) Galantamine\u2014a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer\u2019s disease. CNS Drug Rev 8(2):159\u2013176","journal-title":"CNS Drug Rev"},{"key":"979_CR76","doi-asserted-by":"publisher","DOI":"10.5772\/54744","author":"L Lovre\u010di\u0107","year":"2013","unstructured":"Lovre\u010di\u0107 L, Maver A, Zadel M, Peterlin B (2013) The role of epigenetics in neurodegenerative diseases. Neurodegener Dis. https:\/\/doi.org\/10.5772\/54744","journal-title":"Neurodegener Dis"},{"key":"979_CR77","first-page":"85","volume":"5","author":"H Lu","year":"2013","unstructured":"Lu H, Liu X, Deng Y, Qing H (2013) DNA methylation, a hand behind neurodegenerative diseases. Front Aging Neurosci 5:85","journal-title":"Front Aging Neurosci"},{"issue":"10","key":"979_CR78","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1474-4422(04)00878-6","volume":"3","author":"JA Luchsinger","year":"2004","unstructured":"Luchsinger JA, Mayeux R (2004) Dietary factors and Alzheimer\u2019s disease. Lancet Neurol 3(10):579\u2013587","journal-title":"Lancet Neurol"},{"issue":"9","key":"979_CR79","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/nn.3782","volume":"17","author":"K Lunnon","year":"2014","unstructured":"Lunnon K et al (2014) Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer\u2019s disease. Nat Neurosci 17(9):1164\u20131170","journal-title":"Nat Neurosci"},{"issue":"6","key":"979_CR80","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jama.296.6.661","volume":"296","author":"DM Maraganore","year":"2006","unstructured":"Maraganore DM, De Andrade M, Elbaz A, Farrer MJ, Ioannidis JP, Kr\u00fcger R, Rocca WA, Schneider NK, Lesnick TG, Lincoln SJ (2006) Collaborative analysis of \u03b1-synuclein gene promoter variability and Parkinson disease. JAMA 296(6):661\u2013670","journal-title":"JAMA"},{"issue":"12","key":"979_CR81","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.neurobiolaging.2008.12.005","volume":"31","author":"D Mastroeni","year":"2010","unstructured":"Mastroeni D et al (2010) Epigenetic changes in Alzheimer\u2019s disease: decrements in DNA methylation. Neurobiol Aging 31(12):2025\u20132037","journal-title":"Neurobiol Aging"},{"issue":"11","key":"979_CR82","doi-asserted-by":"crossref","first-page":"15522","DOI":"10.1371\/journal.pone.0015522","volume":"5","author":"L Matsumoto","year":"2010","unstructured":"Matsumoto L, Takuma H, Tamaoka A, Kurisaki H, Date H, Tsuji S, Iwata A (2010) CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson\u2019s disease. PLoS ONE 5(11):15522","journal-title":"PLoS ONE"},{"issue":"3","key":"979_CR83","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1568-1637(03)00013-8","volume":"2","author":"MP Mattson","year":"2003","unstructured":"Mattson MP (2003) Methylation and acetylation in nervous system development and neurodegenerative disorders. Ageing Res Rev 2(3):329\u2013342","journal-title":"Ageing Res Rev"},{"issue":"11","key":"979_CR84","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1158\/0008-5472.CAN-06-2029","volume":"67","author":"KM McGarvey","year":"2007","unstructured":"McGarvey KM, Greene E, Fahrner JA, Jenuwein T, Baylin SB (2007) DNA methylation and complete transcriptional silencing of cancer genes persist after depletion of EZH2. Can Res 67(11):5097\u20135102","journal-title":"Can Res"},{"issue":"3","key":"979_CR85","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1468-1331.2011.03578.x","volume":"19","author":"I Miah","year":"2012","unstructured":"Miah I, Olde Dubbelink K, Stoffers D, Deijen J, Berendse H (2012) Early-stage cognitive impairment in Parkinson\u2019s disease and the influence of dopamine replacement therapy. Eur J Neurol 19(3):510\u2013516","journal-title":"Eur J Neurol"},{"issue":"11","key":"979_CR86","doi-asserted-by":"crossref","first-page":"e27746","DOI":"10.1371\/journal.pone.0027746","volume":"6","author":"M Mielcarek","year":"2011","unstructured":"Mielcarek M, Benn CL, Franklin SA, Smith DL, Woodman B, Marks PA, Bates GP (2011) SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6\/2 mouse model of Huntington\u2019s disease. PLoS ONE 6(11):e27746","journal-title":"PLoS ONE"},{"issue":"4","key":"979_CR87","doi-asserted-by":"crossref","first-page":"280","DOI":"10.5603\/KP.a2014.0209","volume":"73","author":"A Mierzecki","year":"2015","unstructured":"Mierzecki A, Makarewicz-Wujec M, K\u0142oda K, Koz\u0142owska-Wojciechowska M, Pie\u0144kowski P, Naruszewicz M (2015) Influence of folic acid supplementation on coagulation, inflammatory, lipid, and kidney function parameters in subjects with low and moderate content of folic acid in the diet. Kardiologia Polska (Polish Heart J) 73(4):280\u2013286","journal-title":"Kardiologia Polska (Polish Heart J)"},{"issue":"1\u20132","key":"979_CR88","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mrfmmm.2008.10.011","volume":"667","author":"L Migliore","year":"2009","unstructured":"Migliore L, Copped\u00e8 F (2009) Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases. Mutat Res\/Fundam Mol Mech Mutagen 667(1\u20132):82\u201397","journal-title":"Mutat Res\/Fundam Mol Mech Mutagen"},{"issue":"2","key":"979_CR89","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/jcp.21224","volume":"213","author":"TB Miranda","year":"2007","unstructured":"Miranda TB, Jones PA (2007) DNA methylation: the nuts and bolts of repression. J Cell Physiol 213(2):384\u2013390","journal-title":"J Cell Physiol"},{"issue":"8","key":"979_CR90","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/15592294.2020.1722917","volume":"15","author":"N Monti","year":"2020","unstructured":"Monti N, Cavallaro RA, Stoccoro A, Nicolia V, Scarpa S, Kovacs GG, Fiorenza MT, Lucarelli M, Aronica E, Ferrer I (2020) CpG and non-CpG Presenilin1 methylation pattern in course of neurodevelopment and neurodegeneration is associated with gene expression in human and murine brain. Epigenetics 15(8):781\u2013799","journal-title":"Epigenetics"},{"issue":"10","key":"979_CR91","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.tips.2009.07.002","volume":"30","author":"NN Nalivaeva","year":"2009","unstructured":"Nalivaeva NN, Belyaev ND, Turner AJ (2009) Sodium valproate: an old drug with new roles. Trends Pharmacol Sci 30(10):509\u2013514","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"979_CR92","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1073\/pnas.1221292110","volume":"110","author":"CW Ng","year":"2013","unstructured":"Ng CW, Yildirim F, Yap YS, Dalin S, Matthews BJ, Velez PJ, Labadorf A, Housman DE, Fraenkel E (2013) Extensive changes in DNA methylation are associated with expression of mutant huntingtin. Proc Natl Acad Sci 110(6):2354\u20132359","journal-title":"Proc Natl Acad Sci"},{"key":"979_CR93","volume-title":"Dementia: assessment, management and support for people living with dementia and their carers","author":"NICE","year":"2018","unstructured":"NICE (2018) Dementia: assessment, management and support for people living with dementia and their carers. National Institute for Health and Care Excellence, London"},{"issue":"3","key":"979_CR94","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1017\/S0317167100023970","volume":"6","author":"J Nutt","year":"1979","unstructured":"Nutt J, Williams A, Plotkin C, Eng N, Ziegler M, Calne DB (1979) Treatment of Parkinson\u2019s disease with sodium valproate: clinical, pharmacological, and biochemical observations. Can J Neurol Sci 6(3):337\u2013343","journal-title":"Can J Neurol Sci"},{"key":"979_CR95","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-019-01430-0","author":"C Pagiatakis","year":"2019","unstructured":"Pagiatakis C, Musolino E, Gornati R, Bernardini G, Papait R (2019) Epigenetics of aging and disease: a brief overview. Aging Clin Exp Res. https:\/\/doi.org\/10.1007\/s40520-019-01430-0","journal-title":"Aging Clin Exp Res"},{"issue":"2","key":"979_CR96","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1124\/jpet.110.168385","volume":"335","author":"M Pang","year":"2010","unstructured":"Pang M, Zhuang S (2010) Histone deacetylase: a potential therapeutic target for fibrotic disorders. J Pharmacol Exp Ther 335(2):266\u2013272","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"979_CR97","doi-asserted-by":"crossref","first-page":"e31921","DOI":"10.1371\/journal.pone.0031921","volume":"7","author":"R Pi","year":"2012","unstructured":"Pi R, Mao X, Chao X, Cheng Z, Liu M, Duan X, Ye M, Chen X, Mei Z, Liu P (2012) Tacrine-6-ferulic acid, a novel multifunctional dimer, inhibits amyloid-\u03b2-mediated Alzheimer\u2019s disease-associated pathogenesis in vitro and in vivo. PLoS ONE 7(2):e31921","journal-title":"PLoS ONE"},{"issue":"12","key":"979_CR98","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1084\/jem.20081588","volume":"205","author":"H Qing","year":"2008","unstructured":"Qing H, He G, Ly PT, Fox CJ, Staufenbiel M, Cai F, Zhang Z, Wei S, Sun X, Chen C-H (2008) Valproic acid inhibits A\u03b2 production, neuritic plaque formation, and behavioral deficits in Alzheimer\u2019s disease mouse models. J Exp Med 205(12):2781\u20132789","journal-title":"J Exp Med"},{"issue":"6","key":"979_CR99","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1096\/fj.03-0338rev","volume":"18","author":"A Recchia","year":"2004","unstructured":"Recchia A, Debetto P, Negro A, Guidolin D, Skaper SD, Giusti P (2004) \u03b1-Synuclein and Parkinson\u2019s disease. FASEB J 18(6):617\u2013626","journal-title":"FASEB J"},{"issue":"12","key":"979_CR100","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1136\/jmg.25.12.805","volume":"25","author":"W Reik","year":"1988","unstructured":"Reik W (1988) Genomic imprinting: a possible mechanism for the parental origin effect in Huntington\u2019s chorea. J Med Genet 25(12):805\u2013808","journal-title":"J Med Genet"},{"issue":"11","key":"979_CR101","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1111\/bph.12854","volume":"172","author":"M Remely","year":"2015","unstructured":"Remely M, Lovrecic L, De La Garza A, Migliore L, Peterlin B, Milagro F, Martinez A, Haslberger A (2015) Therapeutic perspectives of epigenetically active nutrients. Br J Pharmacol 172(11):2756\u20132768","journal-title":"Br J Pharmacol"},{"issue":"1","key":"979_CR102","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.bbr.2011.03.033","volume":"221","author":"GK Reolon","year":"2011","unstructured":"Reolon GK, Maurmann N, Werenicz A, Garcia VA, Schr\u00f6der N, Wood MA, Roesler R (2011) Posttraining systemic administration of the histone deacetylase inhibitor sodium butyrate ameliorates aging-related memory decline in rats. Behav Brain Res 221(1):329\u2013332","journal-title":"Behav Brain Res"},{"issue":"8","key":"979_CR103","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg1655","volume":"6","author":"KD Robertson","year":"2005","unstructured":"Robertson KD (2005) DNA methylation and human disease. Nat Rev Genet 6(8):597\u2013610","journal-title":"Nat Rev Genet"},{"issue":"3","key":"979_CR104","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1503\/cmaj.050774","volume":"174","author":"D Rodenhiser","year":"2006","unstructured":"Rodenhiser D, Mann M (2006) Epigenetics and human disease: translating basic biology into clinical applications. CMAJ 174(3):341\u2013348","journal-title":"CMAJ"},{"issue":"1","key":"979_CR105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molonc.2007.01.001","volume":"1","author":"S Ropero","year":"2007","unstructured":"Ropero S, Esteller M (2007) The role of histone deacetylases (HDACs) in human cancer. Mol Oncol 1(1):19\u201325","journal-title":"Mol Oncol"},{"issue":"6","key":"979_CR106","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ncpneuro0199","volume":"2","author":"G Sadri-Vakili","year":"2006","unstructured":"Sadri-Vakili G, Cha J-HJ (2006) Mechanisms of disease: histone modifications in Huntington\u2019s disease. Nat Clin Pract Neurol 2(6):330\u2013338","journal-title":"Nat Clin Pract Neurol"},{"issue":"1","key":"979_CR107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-019-1299-4","volume":"17","author":"M Safieh","year":"2019","unstructured":"Safieh M, Korczyn AD, Michaelson DM (2019) ApoE4: an emerging therapeutic target for Alzheimer\u2019s disease. BMC Med 17(1):1\u201317","journal-title":"BMC Med"},{"issue":"4","key":"979_CR108","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/WAD.0000000000000329","volume":"33","author":"D Salcedo-Tacuma","year":"2019","unstructured":"Salcedo-Tacuma D, Melgarejo JD, Mahecha MF, Ortega-Rojas J, Arboleda-Bustos CE, Pardo-Turriago R, Arboleda H (2019) Differential methylation levels in CpGs of the BIN1 gene in Individuals With Alzheimer disease. Alzheimer Dis Assoc Disord 33(4):321\u2013326","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"5","key":"979_CR109","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.peptides.2009.01.027","volume":"30","author":"HM Sanders","year":"2009","unstructured":"Sanders HM, Lust R, Teller JK (2009) Amyloid-beta peptide A\u03b2p3-42 affects early aggregation of full-length A\u03b21-42. Peptides 30(5):849\u2013854","journal-title":"Peptides"},{"issue":"2","key":"979_CR110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","volume":"120","author":"WJ Schulz-Schaeffer","year":"2010","unstructured":"Schulz-Schaeffer WJ (2010) The synaptic pathology of \u03b1-synuclein aggregation in dementia with Lewy bodies, Parkinson\u2019s disease and Parkinson\u2019s disease dementia. Acta Neuropathol 120(2):131\u2013143","journal-title":"Acta Neuropathol"},{"issue":"5","key":"979_CR111","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1208\/s12249-015-0294-0","volume":"16","author":"D Sharma","year":"2015","unstructured":"Sharma D, Sharma RK, Sharma N, Gabrani R, Sharma SK, Ali J, Dang S (2015) Nose-to-brain delivery of PLGA-diazepam nanoparticles. AAPS PharmSciTech 16(5):1108\u20131121","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"979_CR112","first-page":"1479","volume":"20","author":"K Sharma","year":"2019","unstructured":"Sharma K (2019) Cholinesterase inhibitors as Alzheimer\u2019s therapeutics. Mol Med Rep 20(2):1479\u20131487","journal-title":"Mol Med Rep"},{"key":"979_CR113","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3389\/fphar.2020.00537","volume":"11","author":"S Shukla","year":"2020","unstructured":"Shukla S, Tekwani BL (2020) Histone deacetylases inhibitors in neurodegenerative diseases, neuroprotection and neuronal differentiation. Front Pharmacol 11:537","journal-title":"Front Pharmacol"},{"issue":"3","key":"979_CR114","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/NMD.0000000000000107","volume":"202","author":"J Song","year":"2014","unstructured":"Song J, Ahn IS, Kang HS, Myung W, Lee Y, Woo S-y, Ku HM, Hwang T-Y, Carroll BJ, Kim DK (2014) Cognitive subdomain responses to galantamine in Alzheimer\u2019s disease. J Nerv Ment Dis 202(3):253\u2013259","journal-title":"J Nerv Ment Dis"},{"key":"979_CR115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neulet.2014.03.076","volume":"569","author":"Y Song","year":"2014","unstructured":"Song Y, Ding H, Yang J, Lin Q, Xue J, Zhang Y, Chan P, Cai Y (2014) Pyrosequencing analysis of SNCA methylation levels in leukocytes from Parkinson\u2019s disease patients. Neurosci Lett 569:85\u201388","journal-title":"Neurosci Lett"},{"issue":"3","key":"979_CR116","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","volume":"251","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M (1998) Filamentous \u03b1-synuclein inclusions link multiple system atrophy with Parkinson\u2019s disease and dementia with Lewy bodies. Neurosci Lett 251(3):205\u2013208","journal-title":"Neurosci Lett"},{"issue":"12","key":"979_CR117","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","volume":"97","author":"JS Steffan","year":"2000","unstructured":"Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu Y-Z, Gohler H, Wanker EE, Bates GP, Housman DE, Thompson LM (2000) The Huntington\u2019s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci 97(12):6763\u20136768","journal-title":"Proc Natl Acad Sci"},{"issue":"19","key":"979_CR118","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.2169\/internalmedicine.53.2023","volume":"53","author":"K Takaoka","year":"2014","unstructured":"Takaoka K, Hangaishi A, Ito A, Morioka T, Kida M, Usuki K (2014) Late hematological improvement of myelodysplastic syndrome following treatment with 5-azacitidine therapy. Intern Med 53(19):2241\u20132243","journal-title":"Intern Med"},{"issue":"3","key":"979_CR119","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.parkreldis.2013.12.002","volume":"20","author":"Y-y Tan","year":"2014","unstructured":"Tan Y-y, Wu L, Zhao Z-b, Wang Y, Xiao Q, Liu J, Wang G, Ma J-f (2014) Methylation of \u03b1-synuclein and leucine-rich repeat kinase 2 in leukocyte DNA of Parkinson\u2019s disease patients. Parkinsonism Relat Disord 20(3):308\u2013313","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"979_CR120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/mutage\/gel055","volume":"22","author":"P Thomas","year":"2007","unstructured":"Thomas P, Fenech M (2007) A review of genome mutation and Alzheimer\u2019s disease. Mutagenesis 22(1):15\u201333","journal-title":"Mutagenesis"},{"issue":"1","key":"979_CR121","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1749-6632.2009.05175.x","volume":"1199","author":"F Tian","year":"2010","unstructured":"Tian F, Marini AM, Lipsky RH (2010) Effects of histone deacetylase inhibitor Trichostatin A on epigenetic changes and transcriptional activation of Bdnf promoter 1 by rat hippocampal neurons. Ann N Y Acad Sci 1199(1):186\u2013193","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"979_CR122","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrn2132","volume":"8","author":"N Tsankova","year":"2007","unstructured":"Tsankova N, Renthal W, Kumar A, Nestler EJ (2007) Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 8(5):355\u2013367","journal-title":"Nat Rev Neurosci"},{"key":"979_CR123","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/978-1-4419-0639-7_17","volume-title":"Epigenetics of aging","author":"T van Groen","year":"2010","unstructured":"van Groen T (2010) DNA methylation and Alzheimer\u2019s disease. In: Tollefsbo T (ed) Epigenetics of aging. Springer, Berlin, pp 315\u2013326"},{"issue":"1","key":"979_CR124","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1750-1326-1-4","volume":"1","author":"KS Vetrivel","year":"2006","unstructured":"Vetrivel KS, Zhang Y-w, Xu H, Thinakaran G (2006) Pathological and physiological functions of presenilins. Mol Neurodegener 1(1):4","journal-title":"Mol Neurodegener"},{"issue":"2","key":"979_CR125","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/exnr.2001.7630","volume":"168","author":"V Vogelsberg-Ragaglia","year":"2001","unstructured":"Vogelsberg-Ragaglia V, Schuck T, Trojanowski JQ, Lee VM-Y (2001) PP2A mRNA expression is quantitatively decreased in Alzheimer\u2019s disease hippocampus. Exp Neurol 168(2):402\u2013412","journal-title":"Exp Neurol"},{"issue":"7","key":"979_CR126","doi-asserted-by":"crossref","first-page":"821","DOI":"10.4155\/fmc.11.47","volume":"3","author":"M Voronkov","year":"2011","unstructured":"Voronkov M, Braithwaite SP, Stock JB (2011) Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer\u2019s disease. Future Med Chem 3(7):821\u2013833","journal-title":"Future Med Chem"},{"issue":"3","key":"979_CR127","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2217\/epi.14.19","volume":"6","author":"F Wang","year":"2014","unstructured":"Wang F, Fischhaber PL, Guo C, Tang T-S (2014) Epigenetic modifications as novel therapeutic targets for Huntington\u2019s disease. Epigenomics 6(3):287\u2013297","journal-title":"Epigenomics"},{"issue":"7","key":"979_CR128","doi-asserted-by":"crossref","first-page":"e2698","DOI":"10.1371\/journal.pone.0002698","volume":"3","author":"SC Wang","year":"2008","unstructured":"Wang SC et al (2008) Age-specific epigenetic drift in late-onset Alzheimer\u2019s disease. PLoS ONE 3(7):e2698","journal-title":"PLoS ONE"},{"issue":"3","key":"979_CR129","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/cns.12059","volume":"19","author":"Y Wang","year":"2013","unstructured":"Wang Y, Wang X, Li R, Yang ZF, Wang YZ, Gong XL, Wang XM (2013) A DNA methyltransferase Inhibitor, 5-Aza-2\u2032-deoxycytidine, exacerbates neurotoxicity and upregulates Parkinson\u2019s disease-related genes in dopaminergic neurons. CNS Neurosci Ther 19(3):183\u2013190","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"979_CR130","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neulet.2009.10.037","volume":"467","author":"Y Wang","year":"2009","unstructured":"Wang Y, Wang X, Liu L, Wang X (2009) HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells. Neurosci Lett 467(3):212\u2013216","journal-title":"Neurosci Lett"},{"issue":"13","key":"979_CR131","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jama.1994.03510370044030","volume":"271","author":"PB Watkins","year":"1994","unstructured":"Watkins PB, Zimmerman HJ, Knapp MJ, Gracon SI, Lewis KW (1994) Hepatotoxic effects of tacrine administration in patients with Alzheimer\u2019s disease. JAMA 271(13):992\u2013998","journal-title":"JAMA"},{"key":"979_CR132","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1902\/jop.2008.080172","volume":"79","author":"AG Wilson","year":"2008","unstructured":"Wilson AG (2008) Epigenetic regulation of gene expression in the inflammatory response and relevance to common diseases. J Periodontol 79:1514\u20131519","journal-title":"J Periodontol"},{"issue":"6","key":"979_CR133","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1460-9568.2011.07613.x","volume":"33","author":"B Winner","year":"2011","unstructured":"Winner B, Kohl Z, Gage FH (2011) Neurodegenerative disease and adult neurogenesis. Eur J Neurosci 33(6):1139\u20131151","journal-title":"Eur J Neurosci"},{"issue":"12","key":"979_CR134","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/WNR.0b013e328308b355","volume":"19","author":"J-Y Wu","year":"2008","unstructured":"Wu J-Y, Niu F-n, Huang R, Xu Y (2008) Enhancement of glutamate uptake in 1-methyl-4-phenylpyridinium-treated astrocytes by trichostatin A. NeuroReport 19(12):1209\u20131212","journal-title":"NeuroReport"},{"issue":"6","key":"979_CR135","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1096\/fj.11-197251","volume":"26","author":"X Xu","year":"2012","unstructured":"Xu X, Gammon MD, Hernandez-Vargas H, Herceg Z, Wetmur JG, Teitelbaum SL, Bradshaw PT, Neugut AI, Santella RM, Chen J (2012) DNA methylation in peripheral blood measured by LUMA is associated with breast cancer in a population-based study. FASEB J 26(6):2657\u20132666","journal-title":"FASEB J"},{"issue":"6","key":"979_CR136","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.cell.2006.11.033","volume":"127","author":"Y Xu","year":"2006","unstructured":"Xu Y, Xing Y, Chen Y, Chao Y, Lin Z, Fan E, Jong WY, Strack S, Jeffrey PD, Shi Y (2006) Structure of the protein phosphatase 2A holoenzyme. Cell 127(6):1239\u20131251","journal-title":"Cell"},{"issue":"4","key":"979_CR137","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s13670-012-0027-0","volume":"1","author":"Z Xu","year":"2012","unstructured":"Xu Z, Li H, Jin P (2012) Epigenetics-based therapeutics for neurodegenerative disorders. Curr Geriatr Rep 1(4):229\u2013236","journal-title":"Curr Geriatr Rep"},{"issue":"1","key":"979_CR138","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s12035-014-8751-4","volume":"51","author":"A-G Xuan","year":"2015","unstructured":"Xuan A-G, Pan X-B, Wei P, Ji W-D, Zhang W-J, Liu J-H, Hong L-P, Chen W-L, Long D-H (2015) Valproic acid alleviates memory deficits and attenuates amyloid-\u03b2 deposition in transgenic mouse model of Alzheimer\u2019s disease. Mol Neurobiol 51(1):300\u2013312","journal-title":"Mol Neurobiol"},{"key":"979_CR139","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.brainres.2013.02.012","volume":"1504","author":"HH Yeh","year":"2013","unstructured":"Yeh HH, Young D, Gelovani JG, Robinson A, Davidson Y, Herholz K, Mann DM (2013) Histone deacetylase class II and acetylated core histone immunohistochemistry in human brains with Huntington\u2019s disease. Brain Res 1504:16\u201324","journal-title":"Brain Res"},{"issue":"2","key":"979_CR140","doi-asserted-by":"crossref","first-page":"112","DOI":"10.5217\/ir.2015.13.2.112","volume":"13","author":"JM Yi","year":"2015","unstructured":"Yi JM, Kim TO (2015) Epigenetic alterations in inflammatory bowel disease and cancer. Intest Res 13(2):112\u2013121","journal-title":"Intest Res"},{"issue":"1","key":"979_CR141","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1179\/1743132814Y.0000000416","volume":"37","author":"DY Yoo","year":"2015","unstructured":"Yoo DY, Kim DW, Kim MJ, Choi JH, Jung HY, Nam SM, Kim JW, Yoon YS, Choi SY, Hwang IK (2015) Sodium butyrate, a histone deacetylase Inhibitor, ameliorates SIRT2-induced memory impairment, reduction of cell proliferation, and neuroblast differentiation in the dentate gyrus. Neurol Res 37(1):69\u201376","journal-title":"Neurol Res"},{"issue":"5","key":"979_CR142","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1158\/1078-0432.CCR-0989-3","volume":"10","author":"EM Youssef","year":"2004","unstructured":"Youssef EM, Lotan D, Issa J-P, Wakasa K, Fan Y-H, Mao L, Hassan K, Feng L, Lee JJ, Lippman SM (2004) Hypermethylation of the retinoic acid receptor-\u03b22 gene in head and neck carcinogenesis. Clin Cancer Res 10(5):1733\u20131742","journal-title":"Clin Cancer Res"},{"issue":"6","key":"979_CR143","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.04-2751com","volume":"19","author":"W Zhang","year":"2005","unstructured":"Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, Wilson B, Zhang W, Zhou Y, Hong J-S (2005) Aggregated \u03b1-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease. FASEB J 19(6):533\u2013542","journal-title":"FASEB J"},{"issue":"5","key":"979_CR144","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2174\/156720509789207921","volume":"6","author":"N Zhong","year":"2009","unstructured":"Zhong N, Weisgraber KH (2009) Understanding the basis for the association of apoE4 with Alzheimer\u2019s disease: opening the door for therapeutic approaches. Curr Alzheimer Res 6(5):415\u2013418","journal-title":"Curr Alzheimer Res"},{"issue":"3","key":"979_CR145","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.nbd.2008.05.013","volume":"31","author":"X-W Zhou","year":"2008","unstructured":"Zhou X-W, Gustafsson J-\u00c5, Tanila H, Bjorkdahl C, Liu R, Winblad B, Pei J-J (2008) Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A. Neurobiology of disease 31(3):386\u2013394","journal-title":"Neurobiology of disease"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-020-00979-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-020-00979-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-020-00979-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T11:18:58Z","timestamp":1646219938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-020-00979-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":145,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["979"],"URL":"https:\/\/doi.org\/10.1007\/s10571-020-00979-z","relation":{},"ISSN":["0272-4340","1573-6830"],"issn-type":[{"value":"0272-4340","type":"print"},{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,19]]},"assertion":[{"value":"18 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}